C07K 14/4705
Stimulating, promoting or activating activity
Official title: {stimulating, promoting or activating activity}
C07K14/4705 (Stimulating, promoting or activating activity) appears on 1,035 US grants and 1,406 published applications in this corpus.
Search patents in C07K- Granted patents
- 1,035
- Published applications
- 1,406
- Assignees
- 734
- Inventors
- 2,909
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 3 | 0 |
| 1993 | 6 | 0 |
| 1994 | 8 | 0 |
| 1995 | 7 | 0 |
| 1996 | 14 | 0 |
| 1997 | 26 | 0 |
| 1998 | 56 | 0 |
| 1999 | 40 | 0 |
| 2000 | 38 | 0 |
| 2001 | 43 | 5 |
| 2002 | 30 | 50 |
| 2003 | 30 | 64 |
| 2004 | 26 | 55 |
| 2005 | 23 | 61 |
| 2006 | 23 | 47 |
| 2007 | 30 | 35 |
| 2008 | 35 | 44 |
| 2009 | 26 | 52 |
| 2010 | 37 | 38 |
| 2011 | 31 | 34 |
| 2012 | 26 | 32 |
| 2013 | 18 | 40 |
| 2014 | 24 | 65 |
| 2015 | 38 | 56 |
| 2016 | 33 | 45 |
| 2017 | 43 | 50 |
| 2018 | 26 | 58 |
| 2019 | 46 | 54 |
| 2020 | 43 | 68 |
| 2021 | 28 | 83 |
| 2022 | 38 | 83 |
| 2023 | 34 | 79 |
| 2024 | 34 | 88 |
| 2025 | 37 | 75 |
| 2026 | 28 | 45 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Pharmaceutical composition for treatment or prevention of ischemic cardiovascular disease29 Sep 2026US 12,746,220 B2Industry-Academic Cooperation Foundation, Yonsei University
- FOXM1-derived peptide, and vaccine including same29 Sep 2026US 12,747,265 B2Oncotherapy Science, Inc.
- Gene therapy for treatment of CRX-autosomal dominant retinopathies1 Sep 2026US 12,721,908 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Regulated synthetic gene activation systems18 Aug 2026US 12,709,637 B2Trustees of Boston University
- Artificial expression constructs for selectively modulating gene expression in selected neuronal cell populations11 Aug 2026US 12,702,722 B2Allen Insitute
- Genetically engineered human fetal liver niche as platform for biomanufacturing of hematopoietic stem cells1 Oct 2026US 2026/0297528 A1Arizona Board of Regents on behalf of Arizona State University
- Compositions and methods for controlling patterning of human kidney organoid nephrons1 Oct 2026US 2026/0297532 A1University of Southern California
- Pharmaceutical taci-fc fusion protein formulation24 Sep 2026US 2026/0283961 A1Remegen Co., Ltd.
- Activators of the cold stress response and uses thereof24 Sep 2026US 2026/0284050 A1Landspitali University Hospital
- Fusion proteins for improved gene editing24 Sep 2026US 2026/0286397 A1New York Genome Center, Inc.
Most cited
By later US patents
- Binding proteins for recognition of DNA434US 6,007,988 AMedical Research Council · 1999
- Binding proteins for recognition of DNA423US 6,013,453 AMedical Research Council · 2000
- Zinc finger proteins with high affinity new DNA binding specificities409US 5,789,538 AMassachusetts Institute of Technology · 1998
- Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins198US 9,303,079 B2Moderna Therapeutics, Inc. · 2016
- Modified polynucleotides for the production of biologics and proteins associated with human disease196US 8,999,380 B2Moderna Therapeutics, Inc. · 2015